Sculptra is a dermal filler that has been on the market since 1999. It was licenced by the FDA for the first time in 2004 to treat lipoatrophy in HIV patients. Lipoatrophy is a condition that causes facial fat loss, resulting in sunken cheeks, deep folds, and indentations.
Things to know about the Sculptra
Sculptra is a dermal filler that has been on the market since 1999. It was licenced by the FDA for the first time in 2004 to treat lipoatrophy in HIV patients. Lipoatrophy is a condition that causes facial fat loss, resulting in sunken cheeks, deep folds, and indentations.
Sculptra Aesthetic was authorised by the FDA in 2014 to address wrinkles and folds on the face for a more youthful appearance. Poly-L-lactic acid is the major ingredient in Sculptra (PLLA). It's a collagen stimulator that can last up to two years and gives you long-lasting, natural-looking effects.
